As a result, AKT and NF-κB signal pathways are suppressed, which effectively inhibits proliferation, motility, vasculogenic mimicry, and metastasis of lung cancer cells, resulting in strong anticancer effects (Fig. 7). Here, AKT1 is linked to lung carcinoma.